AGITG Trial news: The AGITG currently has fourteen studies open to recruitment and three studies in follow up.
The table below details the AGITG trials that are currently accruing patients.
| Recruited | Target | Recruitment Period (months) | Date of First Site Open (ANZ) | Number of Sites Open | |
| DYNAMIC-III (Colon cancer) | 551 | 1000 | 54 | 09 October 2017 | 41 |
| DYNAMIC-Pancreas (Pancreatic cancer) | 87 | 438 | 54 | 01 March 2019 | 26 |
| DYNAMIC-Rectal (Rectal cancer) | 227 | 408 | 36 | 18 June 2018 | 37 |
| FORECAST-1 (Colorectal cancer) | 28 | 30 | 12 | 11 September 2020 | 4 |
| GENESCREEN 5-FU (Pan Tumour) | 18 | 50 | 50 | 1 February 2021 | 2 |
| INTEGRATE IIa (Gastro-oesophageal cancer) | 78 | 90 | 48 | 19 October 2016 | 27 |
| INTEGRATE IIa – Global | 241 | 350 | 64 | ||
| INTEGRATE IIb | 17 | 92 | 24 | 28 April 2021 | 10 |
| LICPIC (Colorectal cancer) | 48 | 100 | 110 | 11 September 2018 | 2 |
| MASTERPLAN (Pancreatic cancer) | 14 | 120 | 48 | 01 October 2019 | 9 |
| NABNEC (Neuroendocrine tumours) | 54 | 58 | 54 | 15 September 2016 | 18 |
| OXTOX (Colorectal cancer) | 3 | 100 | 18 | 18 December 2020 | 5 |
| PALEO (Oesophageal cancer) | 5 | 54 | 36 | 16 September 2019 | 1 |
| RANDOMS (Pancreatic cancer) | 4 | 60 | 38 | 14 December 2020 | 3 |
| RENO (Rectal cancer) | 38 | 125 | 36 | 21 January 2019 | 7 |
| SPAR (Rectal cancer) | 85 | 222 | 48 | 13 April 2018 | 15 |
| TOP GEAR (Gastric & gastro-oesophageal cancer) | 244 | 280 | 118 | 29 September 2009 | 27 |
| TOP GEAR – Global | 574 | 570 | 41 |
Recruitment figures are for Australian and New Zealand sites as at end June 2021.
Trial Results Lay Summaries (click on the links below):
ABC
Adjuvant GIST/ EORTC 62024
AG0001H
AG9401
ATTAX
ATTAX 2
Advanced GIST
AG9601
A La CaRT
ATTACHE
ATTAX-3
CO.17
CO.20
CO.23
DaVINCI
DECO
ESPAC-3
GAP
GOFURTGO
ICECREAM
IG9401
IMPACT
INTEGRATE
MAGIC
MAX
NSABP CO6
NSABP CO-7
PA.3
PAN 1
QUASAR 2
REGISTER
SCOT
TACTIC
TOP GEAR
TROG 01.04 / IG0103R